Contec Selling General Administrative from 2010 to 2024

300869 Stock   15.48  0.19  1.24%   
Contec Medical's Selling General Administrative is increasing over the years with slightly volatile fluctuation. Selling General Administrative is expected to dwindle to about 10 M. From 2010 to 2024 Contec Medical Selling General Administrative quarterly data regression line had arithmetic mean of  8,734,225 and r-squared of  0.38. View All Fundamentals
 
Selling General Administrative  
First Reported
2019-09-30
Previous Quarter
10.8 M
Current Value
14.5 M
Quarterly Volatility
6.6 M
 
Covid
Check Contec Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Contec Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.9 M, Interest Expense of 47.4 M or Selling General Administrative of 10 M, as well as many indicators such as . Contec financial statements analysis is a perfect complement when working with Contec Medical Valuation or Volatility modules.
  
This module can also supplement various Contec Medical Technical models . Check out the analysis of Contec Medical Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Contec Stock

Contec Medical financial ratios help investors to determine whether Contec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Contec with respect to the benefits of owning Contec Medical security.